Literature DB >> 18758053

Studies on neurosteroids XXV. Influence of a 5alpha-reductase inhibitor, finasteride, on rat brain neurosteroid levels and metabolism.

Yoshiyuki Mukai1, Tatsuya Higashi, Yukiko Nagura, Kazutake Shimada.   

Abstract

In this study, we examined the influence of finasteride (FIN), a 5alpha-reductase inhibitor, on the brain levels and metabolism of neurosteroids [allopregnanolone (AP), 3alpha-dihydroprogesterone (3alpha-DHP), progesterone (PROG), 20alpha-dihydroprogesterone and 11-deoxycorticosterone (DOC)] in rats exposed to immobilization stress. For this purpose, the sensitive, reproducible and accurate liquid chromatography-electrospray ionization-tandem mass spectrometric (LC-ESI-MS/MS) methods that enable the quantification of trace amounts of brain neurosteroids were first developed. The animal study using these methods demonstrated that FIN dose-dependently inhibits the stress-induced elevation of the brain AP, a potent positive modulator of the gamma-aminobutyric acid (GABA) type A receptors, and a 10 mg/kg dose of FIN can almost completely deplete AP in the brains. The study also found that the 20alpha-reduction of PROG is enhanced when its 5alpha-reduction pathway is inhibited in the brains. No change was found in the brain levels of 3alpha-DHP, another GABAergic neurosteroid, and DOC by the administration of FIN.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18758053     DOI: 10.1248/bpb.31.1646

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  19 in total

1.  A stress steroid triggers anxiety via increased expression of α4βδ GABAA receptors in methamphetamine dependence.

Authors:  H Shen; A Mohammad; J Ramroop; S S Smith
Journal:  Neuroscience       Date:  2013-08-29       Impact factor: 3.590

2.  A sensitive and selective LC-differential mobility-mass spectrometric analysis of allopregnanolone and pregnanolone in human plasma.

Authors:  Wen Jin; Michael Jarvis; Michal Star-Weinstock; Margaret Altemus
Journal:  Anal Bioanal Chem       Date:  2013-10-12       Impact factor: 4.142

3.  Neurosteroid withdrawal regulates GABA-A receptor α4-subunit expression and seizure susceptibility by activation of progesterone receptor-independent early growth response factor-3 pathway.

Authors:  O Gangisetty; D S Reddy
Journal:  Neuroscience       Date:  2010-07-27       Impact factor: 3.590

4.  Estrous cycle regulation of extrasynaptic δ-containing GABA(A) receptor-mediated tonic inhibition and limbic epileptogenesis.

Authors:  Xin Wu; Omkaram Gangisetty; Chase Matthew Carver; Doodipala Samba Reddy
Journal:  J Pharmacol Exp Ther       Date:  2013-05-10       Impact factor: 4.030

5.  Endogenous neurosteroid synthesis modulates seizure frequency.

Authors:  Courtney Lawrence; Brandon Scott Martin; Chengsan Sun; John Williamson; Jaideep Kapur
Journal:  Ann Neurol       Date:  2010-05       Impact factor: 10.422

6.  Antiseizure Activity of Midazolam in Mice Lacking δ-Subunit Extrasynaptic GABA(A) Receptors.

Authors:  Sandesh D Reddy; Iyan Younus; Bryan L Clossen; Doodipala Samba Reddy
Journal:  J Pharmacol Exp Ther       Date:  2015-03-17       Impact factor: 4.030

7.  A mouse kindling model of perimenstrual catamenial epilepsy.

Authors:  Doodipala Samba Reddy; Jordan Gould; O Gangisetty
Journal:  J Pharmacol Exp Ther       Date:  2012-03-20       Impact factor: 4.030

8.  The 5α-Reductase Inhibitor Finasteride Exerts Neuroprotection Against Ischemic Brain Injury in Aged Male Rats.

Authors:  Motoki Tanaka; Takunori Ogaeri; Mikhail Samsonov; Masahiro Sokabe
Journal:  Transl Stroke Res       Date:  2018-03-25       Impact factor: 6.829

Review 9.  The influence of stress at puberty on mood and learning: role of the α4βδ GABAA receptor.

Authors:  S S Smith
Journal:  Neuroscience       Date:  2012-10-16       Impact factor: 3.590

10.  Flumazenil decreases surface expression of α4β2δ GABAA receptors by increasing the rate of receptor internalization.

Authors:  Aarti Kuver; Sheryl S Smith
Journal:  Brain Res Bull       Date:  2015-11-22       Impact factor: 4.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.